There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Microsoft (MSFT – Research Report) and Change Healthcare (CHNG – Research Report) with bullish sentiments.
In a report issued on September 25, Brad Zelnick from Credit Suisse maintained a Buy rating on Microsoft, with a price target of $225.00. The company’s shares closed last Monday at $208.55.
According to TipRanks.com, Zelnick is a top 100 analyst with an average return of 18.7% and a 75.9% success rate. Zelnick covers the Technology sector, focusing on stocks such as SS&C Technologies Holdings, Zoom Video Communications, and ZoomInfo Technologies.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Microsoft with a $230.16 average price target, implying a 9.1% upside from current levels. In a report issued on September 11, Wedbush also maintained a Buy rating on the stock with a $260.00 price target.
Change Healthcare (CHNG)
In a report issued on September 25, Jailendra Singh from Credit Suisse maintained a Buy rating on Change Healthcare, with a price target of $19.00. The company’s shares closed last Monday at $14.34, close to its 52-week high of $15.23.
According to TipRanks.com, Singh is a 1-star analyst with an average return of -4.1% and a 38.2% success rate. Singh covers the Healthcare sector, focusing on stocks such as AmerisourceBergen, Cardinal Health, and Owens & Minor.
Currently, the analyst consensus on Change Healthcare is a Strong Buy with an average price target of $17.63, a 23.5% upside from current levels. In a report issued on September 10, Raymond James also reiterated a Buy rating on the stock with a price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.